Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: proceedings (100), actions (831), measures (540), trial (517), procedures (650), dealings (63)

Public given exclusive insight into making of hospital documentary

Description: Members of the public will be given an exclusive insight into the making of a landmark medical ethics documentary on Southampton
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/April-2018/Public-given-exclusive-insight-into-making-of-hospital-documentaryd.aspx

Maternity and Newborn Safety Investigations (MNSI) - patient information

Description: This factsheet explains the Maternity and Newborn Safety Investigations (MNSI) process at University Hospital Southampton NHS Foundation Trust.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Maternity-and-Newborn-Safety-Investigations-MNSI-3163-PIL.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description: Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone Indication • Daratumumab in combination with lenalidomide and dexam
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

Papers Trust Board 27 May 2021

Description: Date Time Location Chair Agenda Trust Board – Open Session 27/05/2021 9:00 - 13:00 Microsoft Teams Peter Hollins 1
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/TB-papers/Papers-Trust-Board-27-May-2021.pdf

Atezolizumab-Bevacizumab-Carboplatin(AUC6)-Paclitaxel

Description: Chemotherapy Protocol LUNG CANCER ATEZOLIZUMAB-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL Regimen  Lung-Atezolizumab-Bevacizumab-Carboplatin (AUC6)-Paclitaxel Indicatio
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab-Bevacizumab-CarboplatinAUC6-Paclitaxel.pdf

Atezolizumab-Bevacizumab

Description: Chemotherapy Protocol Hepatocellular Cancer ATEZOLIZUMAB-BEVACIZUMAB Regimen  HCC-Atezolizumab-Bevacizumab Indication  Atezolizumab in combination with bevacizumab fo
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Atezolizumab-Bevacizumab.pdf

Join us to review plans for a new park and ride and health campus

Description: We invite you to join us for an opportunity to review, discuss and feedback on the latest plans for a permanent
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/January/Join-us-to-review-plans-for-a-new-park-and-ride-and-health-campus.aspx

Could you help guide important research into breast cancer and alcohol awareness?

Description: We're looking for people who would like to be involved in the development of an intervention to help empower women to
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/July-2017/Could-you-help-guide-important-research-into-breast-cancer-and-alcohol-awareness.aspx

Erdafitinib

Description: Regimen • Urothelial - Erdafitinib Chemotherapy Protocol UROTHELIAL CANCER ERDAFITINIB Indication • Monot
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Erdafitinib.pdf

2018: Our year in review

Description: As we prepare to enter 2019, here is a look back at some of the highlights from the past year.
Url: /AboutTheTrust/Newsandpublications/Latestnews/2018/December/2018-Our-year-in-review.aspx

71 to 80 of 609

Previous … 6 7 8 9 10 … Next